SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Florian Douam, Viet Loan Dao Thi, Guillemette Maurin, Judith Fresquet, Dimitri Mompelat, Mirjam B. Zeisel, Thomas F. Baumert, François-Loïc Cosset, Dimitri Lavillette, Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry, Hepatology, 2014, 59, 3
  2. 2
    Isabel Fofana, Nikolaus Jilg, Raymond T. Chung, Thomas F. Baumert, Entry inhibitors and future treatment of hepatitis C, Antiviral Research, 2014, 104, 136

    CrossRef

  3. 3
    Andrea Magri, Simone Bocchetta, Michela Emma Burlone, Rosalba Minisini, Mario Pirisi, Recent advances in HCV entry, Future Virology, 2014, 9, 2, 189

    CrossRef

  4. 4
    Daniel Felmlee, Mohamed Hafirassou, Mathieu Lefevre, Thomas Baumert, Catherine Schuster, Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease, Viruses, 2013, 5, 5, 1292

    CrossRef

  5. 5
    Jason M. Meyer, Gregory A. Graf, Deneys R. van der Westhuyzen, New developments in selective cholesteryl ester uptake, Current Opinion in Lipidology, 2013, 1

    CrossRef

  6. 6
    François Habersetzer, Céline Leboeuf, Michel Doffoël, Mirjam B Zeisel, Thomas F Baumert, Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection, Expert Opinion on Investigational Drugs, 2013, 22, 7, 853

    CrossRef

  7. 7
    Brett D. Lindenbach, Charles M. Rice, The ins and outs of hepatitis C virus entry and assembly, Nature Reviews Microbiology, 2013, 11, 10, 688

    CrossRef

  8. 8
    Guillaume Desoubeaux, Arnaud Daguet, Hervé Watier, Therapeutic antibodies and infectious diseases, Tours, France, November 20−22, 2012, mAbs, 2013, 5, 5, 626

    CrossRef